Oxford Asset Management’s BioDelivery Sciences International, Inc. BDSI Stock Holding History

Oxford Asset Management’s Portfolio BDSI Stock Details BDSI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q1	–	Sell	-147,523	Closed	-$932K	–	1746
2019 Q4	$932K	Sell	147,523 -43,127	-23%	-$253K	0.03%	909
2019 Q3	$803K	Sell	190,650 -565,498	-75%	-$2.42M	0.02%	1050
2019 Q2	$3.52M	Buy	756,148 +159,543	+27%	+$743K	0.08%	387
2019 Q1	$3.16M	Buy	596,605 +76,484	+15%	+$349K	0.07%	371
2018 Q4	$1.92M	Buy	520,121 +380,626	+273%	+$1.34M	0.05%	488
2018 Q3	$379K	Buy	139,495 +55,933	+67%	+$157K	0.01%	1420
2018 Q2	$249K	Sell	83,562 -118,817	-59%	-$282K	﹤0.01%	1541
2018 Q1	$455K	Buy	202,379 +117,998	+140%	+$276K	0.01%	1279
2017 Q4	$245K	Buy	+84,381	New	+$233K	0.01%	1400
2017 Q1	–	Sell	-107,945	Closed	-$189K	–	1576
2016 Q4	$189K	Buy	107,945 +79,599	+281%	+$163K	0.01%	706
2016 Q3	$77K	Sell	28,346 -198,772	-88%	-$505K	﹤0.01%	745
2016 Q2	$536K	Buy	+227,118	New	+$627K	0.02%	580
2013 Q3	–	Sell	-12,467	Closed	-$51K	–	1059
2013 Q2	$51K	Buy	+12,467	New	+$58.5K	﹤0.01%	845

Other funds holding BDSI

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return

NCM

Nantahala Capital Management New Canaan, Connecticut $2.72B AUM 121.58% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

RCMNY

Rubric Capital Management (New York) New York $9.44B AUM 68.42% 1-Year Est. Return

ACA

Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return

SFM

Systematic Financial Management Teaneck, New Jersey $4.36B AUM 40.56% 1-Year Est. Return

Emerald Advisers Leola, Pennsylvania $3.16B AUM 109.58% 1-Year Est. Return

Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Oxford Asset Management's BDSI Position: Q1 2020 in Review

Oxford Asset Management sold out of BioDelivery Sciences International, Inc. (BDSI) in Q1 2020, closing a stake of 147,523 shares — an estimated $932K sold.

Oxford Asset Management first reported a position in BDSI in Q2 2013 and held it in 13 quarters. The position peaked at $3.52M in Q2 2019. 153 funds tracked by Wall St. Rank hold BDSI as of Q1 2020.

Oxford Asset Management reported no remaining BioDelivery Sciences International, Inc. position as of Q1 2020 after selling out during the quarter.
Oxford Asset Management sold 147,523 BioDelivery Sciences International, Inc. shares in Q1 2020, an estimated $932K.
Oxford Asset Management first reported a position in BioDelivery Sciences International, Inc. in Q2 2013 and held it in 13 quarters.
Oxford Asset Management's BioDelivery Sciences International, Inc. position peaked at $3.52M in Q2 2019.
153 funds tracked by Wall St. Rank held BioDelivery Sciences International, Inc. as of Q1 2020.

Based on Oxford Asset Management's 13F filing for Q1 2020, filed 15 May 2020.